Prophylaxis and Treatment Strategy for Endothelial Cell Damages after Hematopoietic Cell Transplantation in Children

Sakaguchi, Hirotoshi; Maemura, Ryo; Yoshida, Nao; Hama, Asahito

doi:10.1016/j.bbmt.2018.12.451

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Of the 5 specifically paediatric studies three [110,111,114] reported no post-BMT complications and two [112,113] reported 27 patients (8.3%) with SOS, TA-TMA or DIC associated with sepsis or engraftment syndrome. All were successfully treated with recombinant thrombomodulin.…”

Section: Adverse Eventsmentioning

confidence: 99%

Danaparoid Sodium: A Review of Its Use in Hepatic Thrombotic Disorders

Magnani¹

2022

Anticoagulation - Current Perspectives

View full text Add to dashboard Cite

Danaparoid sodium is an antithrombotic isolated from porcine mucosa. Its main constituent is a mixture of heparan sulphates that inhibits thrombin generation and also possesses anti-inflammatory and immune-modulatory activity. It has shown safety and efficacy in its main indications of deep venous thrombosis prophylaxis, heparin-induced thrombocytopenia treatment and disseminated intravascular thrombosis treatment. In addition, there are reports of its off-label use for the treatment of portal vein thrombosis in adults and for prevention of the hepatic thrombotic microangiopathies haematogenous that complicate recovery after stem cell transplantation in adults and children. The results of these studies provide further support for its safety and efficacy even in subjects with cirrhosis and/or severe hepatic dysfunction. In this chapter the rationale for danaparoid use is presented and the collated results of comparative studies and case reports are compared with those of other pharmaceutical options for managing these hepatic thrombotic disorders.

show abstract

Section: Adverse Eventsmentioning

confidence: 99%

Danaparoid Sodium: A Review of Its Use in Hepatic Thrombotic Disorders

Magnani¹

2022

Anticoagulation - Current Perspectives

View full text Add to dashboard Cite

show abstract

Prophylaxis and Treatment Strategy for Endothelial Cell Damages after Hematopoietic Cell Transplantation in Children

Cited by 1 publication

References 0 publications

Danaparoid Sodium: A Review of Its Use in Hepatic Thrombotic Disorders

Danaparoid Sodium: A Review of Its Use in Hepatic Thrombotic Disorders

Contact Info

Product

Resources

About